Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedA new revision label (v3.6.2) has been added, replacing the previous v3.6.0. This reflects a minor maintenance update to the page or its underlying documentation rather than a change to study details or user-facing features.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now indicates that it is no longer recruiting participants. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header, accompanied by a revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check24 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new platform build. This change does not affect study details or other visible content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision metadata was updated from v3.5.3 to v3.5.4, representing a small version bump. This change does not modify visible content or behavior.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s displayed site revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor backend or UI release rather than a change to the trial record content.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.